Elizabeth L. Ciemins

Elizabeth L. Ciemins

Auto-generated profile, based on publicly available information

Elizabeth L. Ciemins

American Medical Group Association, Alexandria, Virginia (E.C.).

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2024 in Circulation
Verified
Journal Article
Closed access
SKSadiya S. Khan
Sadiya S. Khan
KMKunihiro Matsushita
Kunihiro Matsushita
YSYingying Sang
Yingying Sang
SBShoshana H. Ballew
Shoshana H. Ballew
MGMorgan E. Grams
Morgan E. Grams
FGfor the Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group
for the Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group
BACKGROUND: Multivariable equations are recommended by primary prevention guidelines to assess absolute risk of cardiovascular disease (CVD). However, current equations have several limitations. Therefore, we developed and validated the American Heart Association Predicting Risk of CVD EVENTs (PREVENT) equations among US adults 30 to 79 years of age without known CVD. METHODS: The derivation sample included individual-level participant data from 25 data sets (N=3 281 919) between 1992 and 2017. The primary outcome was CVD (atherosclerotic CVD and heart failure). Predictors included traditional risk factors (smoking status, systolic blood pressure, cholesterol, antihypertensive or statin use, and diabetes) and estimated glomerular filtration rate. Models were sex-specific, race-free, developed on the age scale, and adjusted for competing risk of non-CVD death. Analyses were conducted in each data set and meta-analyzed. Discrimination was assessed using the Harrell C-statistic. Calibration was calculated as the slope of the observed versus predicted risk by decile. Additional equations to predict each CVD subtype (atherosclerotic CVD and heart failure) and include optional predictors (urine albumin-to-creatinine ratio and hemoglobin A1c), and social deprivation index were also developed. External validation was performed in 3 330 085 participants from 21 additional data sets. RESULTS: Among 6 612 004 adults included, mean±SD age was 53±12 years, and 56% were women. Over a mean±SD follow-up of 4.8±3.1 years, there were 211 515 incident total CVD events. The median C-statistics in external validation for CVD were 0.794 (interquartile interval, 0.763–0.809) in female and 0.757 (0.727–0.778) in male participants. The calibration slopes were 1.03 (interquartile interval, 0.81–1.16) and 0.94 (0.81–1.13) among female and male participants, respectively. Similar estimates for discrimination and calibration were observed for atherosclerotic CVD– and heart failure–specific models. The improvement in discrimination was small but statistically significant when urine albumin-to-creatinine ratio, hemoglobin A1c, and social deprivation index were added together to the base model to total CVD (ΔC-statistic [interquartile interval] 0.004 [0.004–0.005] and 0.005 [0.004–0.007] among female and male participants, respectively). Calibration improved significantly when the urine albumin-to-creatinine ratio was added to the base model among those with marked albuminuria (>300 mg/g; 1.05 [0.84–1.20] versus 1.39 [1.14–1.65]; P =0.01). CONCLUSIONS: PREVENT equations accurately and precisely predicted risk for incident CVD and CVD subtypes in a large, diverse, and contemporary sample of US adults by using routinely available clinical variables.

7 July 2021 in Diabetes Care
Verified
Journal Article
Open access
PDF file
NSNikita Stempniewicz
Nikita Stempniewicz
JVJoseph A. Vassalotti
Joseph A. Vassalotti
JCJohn K. Cuddeback
John K. Cuddeback
ECElizabeth Ciemins
Elizabeth Ciemins
ASAmy Storfer-Isser
Amy Storfer-Isser
JCJosef Coresh
Josef Coresh
OBJECTIVE: Clinical guidelines for people with diabetes recommend chronic kidney disease (CKD) testing at least annually using estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (uACR). We aimed to understand CKD testing among people with type 2 diabetes in the U.S. RESEARCH DESIGN AND METHODS: Electronic health record data were analyzed from 513,165 adults with type 2 diabetes receiving primary care from 24 health care organizations and 1,164 clinical practice sites. We assessed the percentage of patients with both one or more eGFRs and one or more uACRs and each test individually in the 1, 2, and 3 years ending September 2019 by health care organization and clinical practice site. Elevated albuminuria was defined as uACR ≥30 mg/g. RESULTS: The 1-year median testing rate across organizations was 51.6% for both uACR and eGFR, 89.5% for eGFR, and 52.9% for uACR. uACR testing varied (10th–90th percentile) from 44.7 to 63.3% across organizations and from 13.3 to 75.4% across sites. Over 3 years, the median testing rate for uACR across organizations was 73.7%. Overall, the prevalence of detected elevated albuminuria was 15%. The average prevalence of detected elevated albuminuria increased linearly with uACR testing rates at sites, with estimated prevalence of 6%, 15%, and 30% at uACR testing rates of 20%, 50%, and 100%, respectively. CONCLUSIONS: While eGFR testing rates are uniformly high among people with type 2 diabetes, testing rates for uACR are suboptimal and highly variable across and within the organizations examined. Guideline-recommended uACR testing should increase detection of CKD.

1 July 2016 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
ECElizabeth L. Ciemins
Elizabeth L. Ciemins
JBJeannine Brant
Jeannine Brant
DKDiane Kersten
Diane Kersten
EMElizabeth Mullette
Elizabeth Mullette
DDDustin Dickerson
Dustin Dickerson
Background: Although an interdisciplinary approach is considered best practice for caring for patients at the end of life, or in need of palliative care (PC) services, there is growing tension between healthcare organizations' need to contain costs and the provision of this beneficial, yet resource-intensive service. Objective: To support the interdisciplinary team (IDT) approach by recognizing organizations, teams, patients, and families as complex adaptive systems, illustrated by a qualitative study of the experiences, roles, and attributes of healthcare professionals (HCPs) who work with patients in need of PC services. Design: In-depth, semi-structured interviews of PC health professionals were conducted, transcribed, and independently reviewed using grounded theory methodology and preliminary interpretations. A combined deductive and inductive iterative qualitative approach was used to identify recurring themes. Setting/Subjects: The study was conducted in a physician-led, not-for-profit, multispecialty integrated health system serving three large, Western, rural states. A purposive sample of 10 HCPs who regularly provide PC services were interviewed. Results: A positive team/patient experience was related to individual attributes, including self-awareness, spirit of inquiry, humility, and comfort with dying. IDT attributes included shared purpose, relational coordination, holistic thinking, trust, and respect for patient autonomy. Professional and personal motivations also contributed to a positive team/patient experience. Conclusions: Interdisciplinary PC teams have the potential to significantly impact patient and team experiences when caring for seriously ill patients. Findings from this study support interventions that focus on relationship building and application of a complex systems theory approach to team development.

4 March 2024 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
ECElizabeth L. Ciemins
Elizabeth L. Ciemins
JMJeff T. Mohl
Jeff T. Mohl
CMCarlos A. Moreno
Carlos A. Moreno
FCFrancis Colangelo
Francis Colangelo
RSRobert A. Smith
Robert A. Smith
MBMary Barton
Mary Barton
Colorectal cancer (CRC) is the third leading cause of cancer deaths in men and women in the US, and it is estimated that there will be approximately 53 000 deaths due to CRC in 2023.1 Screening for CRC is widely recommended2-5 because, when identified early, CRC is one of the most treatable forms of cancer, with a 5-year survival rate of 90%.6,7 In contrast, the 5-year survival rate among those diagnosed with late-stage disease is only 14%.7 Currently, only 33% of CRCs are diagnosed at the earliest stage.1 Individuals with an abnormal result of a stool-based screening test (SBT) must receive timely follow-up with a colonoscopy because patients experience increased negative clinical outcomes, such as later-stage diagnosis, when follow-up after an abnormal SBT result is delayed by more than 6 to 12 months.8-10 Diagnosis at an early stage will reduce neoplastic progression of disease8-10 and therefore increase the possibility of curative treatment.9 It follows that early diagnosis may also decrease downstream complications, improve outcomes, and minimize costs to the patient and the health care system.11 Further, early diagnosis helps reduce racial and ethnic disparities in outcomes: when CRC is diagnosed at a localized stage, survival rates are comparable across racial and ethnic groups.12

7 October 2020 in Obesity
Verified
Journal Article
Open access
PDF file
ECElizabeth L. Ciemins
Elizabeth L. Ciemins
VJVaishali Joshi
Vaishali Joshi
JCJohn K. Cuddeback
John K. Cuddeback
RKRobert F Kushner
Robert F Kushner
DHDeborah B. Horn
Deborah B. Horn
WGW. Timothy Garvey
W. Timothy Garvey
Objective: This study aimed to explore the relationship between an obesity diagnosis and weight loss as a percentage of total body weight loss over 9 to 15 months, using electronic health record data.Methods: An observational study of 688,878 adult patients at 15 health systems with BMI ≥ 30 kg/m2 examined the relationship between weight loss and documentation of obesity diagnosis. Multivariable logistic regression models were created using a stepwise backwards elimination procedure to identify potential predictors of weight loss.Results: Of patients with BMI ≥ 30, 44.9% had an obesity diagnosis on a claim or electronic health record problem list; 16.9% and 5.9% lost ≥ 5% and ≥ 10% of their body weight, respectively. Multivariable logistic regression models revealed a diagnosis of obesity on the same day as the initial weight (odds ratio [OR] = 1.3; CI: 1.2‐1.3; P < 0.001) as a predictor of ≥ 5% total body weight loss in 9 to 15 months. Other significant predictors included an antiobesity medication prescription, female sex, diagnosis of type 2 diabetes, Medicare/Medicaid insurance, and number of ambulatory visits.Conclusions: While controlling for potentially confounding factors, documentation of an obesity diagnosis remained independently predictive of at least 5% weight loss. This suggests that documenting a diagnosis of obesity may be an important step toward engaging patients to lose weight.

18 August 2019 in Health Services Management Research
Verified
Journal Article
Closed access
PDF file
ECElizabeth L Ciemins
Elizabeth L Ciemins
BMBrenda L Mollis
Brenda L Mollis
JBJeannine M Brant
Jeannine M Brant
LHLaurie A Hassell
Laurie A Hassell
SASandra Albritton
Sandra Albritton
LBLaura-Mae Baldwin
Laura-Mae Baldwin
Introduction: Increased research engagement of frontline, community-based clinicians could result in greater research relevancy, increased likelihood of implementation into practice, and improved health care for patients. Establishment of learning health systems within health-care organizations may facilitate this process. Methods: In 2016, the U.S. Northwest Participant and Clinical Interactions Network conducted a region-wide survey in four community-based health systems to identify barriers to clinician involvement in research and understand clinician interest and levels of engagement. Results: Survey responses indicated broad interest in research’s value to patients (77% of respondents), contribution to clinical evidence (79%), and fulfillment of intellectual curiosity (77%). Engagement was not always correlated with interest. Top barriers included time (65%), support (34%), and getting started (32%). Conclusion: In community health systems in the northwestern United States, clinician interest in research exists but with several significant barriers. Leveraging the learning health system movement may be one way to increase focus on research and address identified barriers.